Bart Dzikowski
InvestorManaging Director at Novartis Venture Fund
Basel, Switzerland
Writes $5M – $10M checks · typically $7.5M
About
Bart Dzikowski is a Managing Director at the Novartis Venture Fund, where he heads Transactions & Legal. Before this role he held senior positions in Novartis' Transactions groups, which he joined in 2009, and earlier worked as a VP in investment banking at Bank of America/Merrill Lynch and as a transactions attorney at Allen & Overy in New York. He holds Juris Doctor and Civil Law degrees from McGill Law School and is a member of the New York State Bar.
Invests in
Biotech
Experience
- NovartisManaging Director, Head of Transactions & Legal, Novartis Venture Fundcurrent2009 — presentBasel Area, Switzerland
- Amphista Therapeutics LimitedBoard Directorcurrent2023 — presentCambridge, England, United Kingdom
- Enterprise Therapeutics (TMEM16A Acquired by Roche)Board Directorcurrent2018 — presentLondon, United Kingdom
- UZH Life Sciences FundBoard Directorcurrent2020 — presentZurich, Switzerland
- OculisBoard Director (Until Public Listing)2019 — 2023Lausanne Metropolitan Area
- Inflazome LtdBoard Director (Until Acquisition by Roche)2019 — 2020Dublin, Ireland
- F2GBoard Observer2015 — 2017London, United Kingdom
- Aeglea BioTherapeuticsBoard Observer (Until Public Listing)2014 — 2016Austin, Texas
- Sosei HeptaresBoard Observer (Until Acqusition by Sosei)2014 — 2015London, United Kingdom
- Bank of America Merrill LynchVice-President2006 — 2009New York City Metropolitan Area
- Allen & OveryAssociate2001 — 2006New York City Metropolitan Area
Education
- McGill UniversityJ.D. / B.C.L., Law1999 — 2002
- Queen's UniversityB.A. (Hons.), History & Pol. Sci.1995 — 1999
Skills & more
Investments5Due Diligence9Mergers & Acquisitions36Licensing13Venture Capital20Restructuring7Mergers6Corporate Law23Corporate Governance7Business Development6Securities3Legal Advice5
+6 more
Intellectual PropertyBusiness StrategySecurities RegulationPrivate EquityJoint VenturesMergers & Acquisitions (M&A)- Admitted to Practice Law in the State of New York — New York State Bar Association
- Admitted to practice law before the Southern Federal District Courts of New York — U.S. District Court, Southern District of New York
From Bart's professional profile.
Same school
Also attended McGill University322
Harley FinkelsteinInvestor at Felicis VenturesMattias LjungmanInvestor at Moonfire VenturesNoubar AfeyanInvestor at Flagship PioneeringDavid NaultGeneral Partner at Luge CapitalLaviva MazharPrincipal at Luge CapitalLisa PurcellInvestor at Third Rock Ventures
+ 316 more
Also attended Queen's University173
Hark AhluwaliaAssociate at RevolutionSydney SloanChief Marketing Officer at Scale Venture PartnersRares CrisanInvestor at GGV CapitalCURTIS URBANOWICZInvestment at Makers FundSanjiv KalevarPartner at Mucker CapitalAustin PringleAnalyst at Congruent Ventures
+ 167 more
Shared employers
Also worked at Amphista Therapeutics Limited3
Also worked at Oculis3
Also worked at F2G2
Also worked at Sosei Heptares1
Investments
Board seats
AmphistaEnterprise Therapeutics
Investor
RhyGaze
Per the firm's website.
Colleagues at Novartis Venture Fund
Aaron Nelson
Managing Director at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Network5
Aaron Nelson
Managing Director at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Florian Muellershausen
Managing Director at Novartis Venture Fund
Investors connected to Bart in public investor directories — a warm-intro map.